Stay updated on Pembrolizumab in Hypermutation Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.

Latest updates to the Pembrolizumab in Hypermutation Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedMinor version update from v3.5.0 to v3.5.2 with no visible changes to study details or on-page content.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check41 days agoChange DetectedRevision: v3.5.0 added and v3.4.3 removed.SummaryDifference0.0%

- Check48 days agoChange DetectedRevision: v3.4.3 released. The page content appears unchanged aside from the version label.SummaryDifference0.0%

- Check55 days agoChange DetectedResults have been posted for the study, including ORR, PFS, and OS outcomes with posting dates. The page now includes links to the study protocol and statistical analysis plan.SummaryDifference3%

- Check77 days agoChange DetectedRevision: v3.4.2 was added to the page. The government funding lapse notice and the v3.4.1 revision information were removed.SummaryDifference0.4%

- Check84 days agoChange DetectedAdded a government funding lapse notice at the top of the page and updated the site version to v3.4.1, replacing v3.4.0; these are administrative UI changes that do not affect study details, and to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Hypermutation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Hypermutation Clinical Trial page.